Johnson & Johnson has built a strong, resilient supply base by integrating its suppliers as an expansion of our network and capabilities. Our suppliers reflect all facets of the communities we serve. Through our Supplier-Enabled Innovation program, we leverage their diverse and unique expertise to co-create innovative solutions that address unmet needs and reimagine the future of health.
Faced with the challenge of improving stapling performance for consistent outcomes in challenging tissue, Ethicon drew inspiration from its broad and talented supplier base.
In China, when the need for a highly advanced, nonsurgical treatment for atrial fibrillation (AFib) exceeded the supply of doctors trained in the lifesaving procedure, Johnson & Johnson’s Procurement team asked for a chance to help. Thanks to quick actions and truly disruptive thinking, a new innovation in sourced artificial intelligence (AI) is now responsible for training physicians and, in turn, changing the trajectory of health for AFib patients throughout the country.
Harnessing the immune system to target cancer is the goal of a groundbreaking area of oncology research called cell therapy. And Johnson & Johnson is hard at work in the cutting-edge field, aiming to deliver potential new treatment options to people around the world.
From backing an app that connects Black women to caregivers of color to developing a digital platform that supports surgical recovery, Johnson & Johnson is helping drive the surge of innovation in telemedicine.
Multifocal contacts based on your pupil size. Intraocular lenses that adapt to our digital world. These are just some of the new Johnson & Johnson advances poised to change the future of vision care.
Certain gene mutations can dramatically increase the risk of developing aggressive prostate cancer. That’s why Johnson & Johnson is researching a new way to fight the disease—one that involves blocking cancer cells from repairing their own damaged DNA.